- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00190216
Assessing Repetitive Transcranial Magnetic Stimulation as a Treatment for Refractory Depression (rTMS)
Assessing Repetitive Transcranial Magnetic Stimulation as a Treatment for Refractory Depression
Studieoversikt
Detaljert beskrivelse
The objectives of the study were :
- To localize the site of lowest frontal activity in each patient with resistant depression, using PET to measure regional cerebral metabolic rates for glucose (rCMRGlu).
- To demonstrate that high-frequency TMS (10Hz) guided on that site is more effective than standard or sham TMS, in resistant depressed patients, using a doubled blind controlled procedure.
- To assess the effects of TMS on regional cerebral metabolism using rCMRGlu PET after 10 sessions of TMS treatments.
Depressed patients meeting DSM-IV criteria for Major Depressive Disorder, aged between 18 and 55, have been included. They met criteria for depression resistant to antidepressant drugs They were randomised in 3 groups: guided prefrontal TMS, standard left prefrontal and sham left prefrontal TMS.
rTMS was administered daily on working days, for two weeks. Ten stimuli per second (10Hz) were applied in 20 courses so that patients received 1600 stimuli per day. Guided TMS was on a prefrontal target corresponding to the highest statistically significant hyperfunctional cluster determined with rCMRGlu PET. Standard stimulation was left pre-frontal, 5 cm anterior to the optimal stimulation point of the abductor pollices brevis. Stimulation strength was chosen at 90% relative to motor threshold. Sham rTMS used a procedure identical to the real standard treatment, but using a sham coil.
Studietype
Registrering (Faktiske)
Fase
- Fase 3
Kontakter og plasseringer
Studiesteder
-
-
-
Creteil, Frankrike, 94000
- Albert Chenevier Hospital, Department of psychiatry
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Major depression (according to DSM-IV)resistant to at least two medical antidepressant treatment of different pharmacological action, prescribed for at least one month each at an effective dosage, without therapeutical result.
- Hospitalisation in the service of an investigator
- Informed consent signed
Exclusion Criteria:
- Presence of metallic parts inside the body (pace-maker, vascular clip, cardiac valve, prothesis...)
- Severe somatic or central nervous system disease
- Familial history of comitiality
- Pregnancy
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: EN
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
The primary outcome will be measured at 2 weeks, using depression scales scores : Hamilton depression rating scale, and Montgomery and Asberg Depression Rating Scale
Tidsramme: at 2 weeks
|
at 2 weeks
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
---|---|
Depressive psychomotor retardation will be assessed at 2 weeks
Tidsramme: at 2 weeks
|
at 2 weeks
|
All depression measures will be assessed at 4 weeks, 2 weeks after the end of the trial to evaluate the lasting effects.
Tidsramme: at 4 weeks, 2 weeks after the end of the trial
|
at 4 weeks, 2 weeks after the end of the trial
|
Samarbeidspartnere og etterforskere
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Marie-Laure PAILLERE MARTINOT, MD; PhD, Assistance Publique - Hôpitaux de Paris
Studierekorddatoer
Studer hoveddatoer
Studiestart
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- AOM98099
- P000606
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Magnetic stimulator
-
National Institute of Neurological Disorders and...FullførtSunn | Parkinsons sykdom | Demens | Cerebellar sykdomForente stater
-
Cervel Neurotech, Inc.FullførtDepressiv lidelse, majorForente stater
-
Chang Gung Memorial HospitalRekruttering
-
The Mind Research NetworkUniversity of New MexicoRekrutteringTranskraniell magnetisk stimulering | Traumatisk hjerneskade | Magnetisk resonansavbildning | Post-hjernerystelse syndrom | Nevropsykologiske testerForente stater
-
University of OklahomaTilbaketrukketBetennelse | STEMI - ST Elevation MyokardinfarktForente stater
-
Medical University of LodzRekruttering
-
Xuanwu Hospital, BeijingUkjent
-
Institut National de la Santé Et de la Recherche...Fullført
-
Pusan National UniversityUkjent
-
Assaf-Harofeh Medical CenterFullførtType 2 diabetes mellitusIsrael